How much does a box of regular Epclusa medicines cost?

Epclusa is a broad-spectrum anti-hepatitis C virus (HCV) drug that is widely used to treat chronic hepatitis C infection of various genotypes. This drug is highly recognized by patients and doctors for its remarkable efficacy and low side effects. At present, Jisandai has been officially launched in China and has been included in the national medical insurance directory, which has greatly reduced the financial burden of patients.

in the country, the regular price of Jisandai’s medicines is about more than 3,000 yuan per box. Patients can purchase the drug through hospitals or regular pharmacies, and the specific price will vary depending on the region and medical insurance policies. Due to the inclusion in medical insurance, the actual amount paid by patients under the reimbursement policy will be significantly reduced. It is recommended that patients consult the local hospital pharmacy to learn about the latest prices and medical insurance reimbursement ratios when purchasing.

In contrast, in foreign markets, especially in countries such as India and Bangladesh, generic versions of Jisandai are produced. These generic drugs are more affordable, usually only a few hundred yuan per box. Although the price is lower, the pharmaceutical ingredients of these generic drugs are basically the same as those of regular domestic original drugs, and they have undergone certain quality supervision. Some patients choose to obtain these generic drugs through overseas channels to reduce the cost of treatment.

Overall, the domestic launch of Jisanda and its inclusion in medical insurance have made this advanced treatment drug affordable for more hepatitis C patients. Patients should choose appropriate drug purchase channels and treatment plans based on their own conditions, combined with doctor's advice and medical insurance policies, to ensure the safety and effectiveness of treatment.

Reference: https://www.epclusa.com/